Exelixis
EXEL
#1888
Rank
โ‚น1.053 T
Marketcap
โ‚น4,146
Share price
-1.75%
Change (1 day)
23.85%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: โ‚น4,674 INR on 2000-07-26

Lowest end of day price: โ‚น122.43 INR on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026-0.34%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
โ‚น21,563-1.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2,499-1.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31,303-4.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4,373-1.07%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น10,645 2.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5,526-3.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4,898-1.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น56.19-1.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,424 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA